Monoclonal antibody OKT3 therapy in pediatric kidney transplant recipients
- 1 May 1990
- journal article
- research article
- Published by Elsevier BV in The Journal of Pediatrics
- Vol. 116 (5), S86-S91
- https://doi.org/10.1016/s0022-3476(05)82708-8
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- INFLUENCE OF LOW-DOSE CYCLOSPORINE ON THE OUTCOME OF TREATMENT WITH OKT3 FOR ACUTE RENAL ALLOGRAFT REJECTIONTransplantation, 1989
- OKT3 SALVAGE THERAPY IN A QUADRUPLE IMMUNO SUPPRESSIVE PROTOCOL IN CADAVERIC RENAL TRANSPLANTATIONTransplantation, 1989
- EFFECTIVENESS OF A SECOND COURSE OF 0KT3 MONOCLONAL ANTI-T CELL ANTIBODY FOR TREATMENT OF RENAL ALLOGRAFT REJECTIONTransplantation, 1988
- OKT3 monoclonal antibody in pediatric kidney transplant recipients with recurrent and resistant allograft rejectionThe Journal of Pediatrics, 1987
- OKT3 TREATMENT OF STEROID-RESISTANT RENAL ALLOGRAFT REJECTIONTransplantation, 1987
- Tolerance to rat monoclonal antibodies. Implications for serotherapy.The Journal of Experimental Medicine, 1986
- ANTI-IDIOTYPIC AND NON-ANTI-INDIOTYPIC ANTIBODIES TO OKT3 ARISING DESPITE INTENSE IMMUNOSUPPRESSIONTransplantation, 1986
- MONOCLONAL ANTIBODY FOR REVERSAL OF ACUTE RENAL ALLOGRAFT REJECTION IN PEDIATRIC PATIENTSTransplantation, 1985
- A Randomized Clinical Trial of OKT3 Monoclonal Antibody for Acute Rejection of Cadaveric Renal TransplantsNew England Journal of Medicine, 1985
- TREATMENT OF ACUTE RENAL ALLOGRAFT REJECTION WITH OKT3 MONOCLONAL ANTIBODYTransplantation, 1981